AGS Tx

AGS Therapeutics develops innovative human therapeutics and vaccines based on the outstanding features of the extracellular vesicles from microalgae (MEV).

MEV are a safe, targeted and highly versatile delivery system for innovative biologics, such as mRNA, siRNA, DNA, peptides, and proteins for a broad range of human diseases.
Some relevant features of MEV, such as their oral availability, their fine-tune access to the spleen, or their capacity to easily target selected regions of the brain, open new unexpected avenues for the treatment and prevention of severe human conditions.

AGS’ MEV are easy to manufacture in large quantities with production techniques that are easily scalable and industrializable.
AGS’ MEV are derived from Chlorella, a two-billion-year-old single-cell algae used for decades as a food supplement. Production of AGS’ MEV is a simple, green, eco-friendly activity that requires water, minerals, and light, only.

AGS-M is a subsidiary company of AGS Therapeutics, fully dedicated to the development of suitable processes for the bioproduction - purification of MEV, and to the manufacturing of MEV batches aimed at supporting the preclinical and clinical development of MEV-based products from AGS Therapeutics and its pharma partners.